Friess Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-710
Closed -$362K 85
2022
Q1
$362K Buy
+710
New +$342K 0.19% 83
2020
Q2
Sell
-55,000
Closed -$13.7M 131
2020
Q1
$13.7M Buy
+55,000
New +$15.1M 1.37% 33
2019
Q2
Sell
-66,828
Closed -$16.5M 141
2019
Q1
$16.5M Buy
66,828
+7,653
+13% +$1.95M 1.21% 41
2018
Q4
$14.7M Buy
+59,175
New +$15.6M 1.26% 41
2017
Q1
Sell
-82,590
Closed -$13.2M 162
2016
Q4
$13.2M Sell
82,590
-39,781
-33% -$5.94M 1.3% 42
2016
Q3
$17.1M Hold
122,371
1.66% 19
2016
Q2
$17.3M Hold
122,371
1.77% 17
2016
Q1
$15.8M Buy
122,371
+15
+0% +$1.77K 1.58% 25
2015
Q4
$14.4M Buy
122,356
+28,800
+31% +$3.37M 1.34% 40
2015
Q3
$10.9M Hold
93,556
1.01% 51
2015
Q2
$11.4M Hold
93,556
0.95% 55
2015
Q1
$11.1M Sell
93,556
-2,720
-3% -$302K 0.89% 54
2014
Q4
$9.73M Buy
96,276
+1,625
+2% +$154K 0.78% 53
2014
Q3
$8.16M Sell
94,651
-68,046
-42% -$5.75M 0.7% 56
2014
Q2
$13.3M Sell
162,697
-158,763
-49% -$12.5M 1.08% 44
2014
Q1
$26.4M Buy
321,460
+320,000
+21,918% +$24.1M 2.06% 12
2013
Q4
$110K Buy
1,460
+60
+4% +$4.31K 0.01% 122
2013
Q3
$100K Hold
1,400
0.01% 115
2013
Q2
$92K Buy
+1,400
New +$87.1K 0.01% 123

Other funds holding UNH

Friess Associates's UNH Position: Q2 2022 in Review

Friess Associates sold out of UnitedHealth (UNH) in Q2 2022, closing a stake of 710 shares — an estimated $362K sold.

Friess Associates first reported a position in UNH in Q2 2013 and held it in 19 quarters. The position peaked at $26.4M in Q1 2014. 2,958 funds tracked by Wall St. Rank hold UNH as of Q2 2022.

  • Friess Associates reported no remaining UnitedHealth position as of Q2 2022 after selling out during the quarter.
  • Friess Associates sold 710 UnitedHealth shares in Q2 2022, an estimated $362K.
  • Friess Associates first reported a position in UnitedHealth in Q2 2013 and held it in 19 quarters.
  • Friess Associates's UnitedHealth position peaked at $26.4M in Q1 2014.
  • 2,958 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.